Paras Vakharia is a Dermatology pharmacist affiliated with Northwestern University. OpenAlex indexes 80 publications with 2,156 citations (h-index 24); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
676 N Saint Clair St Ste 1600
Chicago, IL 606112997
Telephone
312-695-0307Provider last certified this registry record 26 Jun 2022.
Clinical trials
- Tapinarof for Cutaneous Lupus Erythematosus
Sponsor: Northwestern University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GENZYME CORPORATIONProgram year20256 payments
- Janssen Biotech, Inc.Program year20253 payments
- ABBVIE INC.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
32.8%Corticosteroid21.9%Triamcinolone Acetonide81%Triamcinolone acetonide12%Fluocinolone Acetonide7%Part D + Part B<11 patientsInterleukin-4 Receptor alpha Antagonist8%Dupixent Pen83%Dupixent Syringe18%Part D<11 patients+ 2 more classes in this area
Anti-infectives
20.3%Azole Antifungal9.5%Ketoconazole100%Part D≥78 patientsTetracycline-class Drug5.5%Doxycycline Monohydrate81%Doxycycline Hyclate19%Part D<11 patients+ 2 more classes in this area
Sensory organs
14.1%Corticosteroid13%Clobetasol Propionate60%Hydrocortisone22%Betamethasone Diprop Augmented7%Betamethasone Dipropionate6%Betamethasone Valerate6%Part D<11 patientsAminoglycoside Antibacterial1.1%Gentamicin Sulfate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Methods to Validate Digital Health Technologies for Dermatology
Journal of Investigative Dermatology
2025 - Validity and reliability of Patient-Reported Outcomes Measurement Information System Global Health scale in adults with atopic dermatitis
Journal of the American Academy of Dermatology
2021 - Association of atopic dermatitis severity with cognitive function in adults
Journal of the American Academy of Dermatology
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Clyde Yancy, MD
Northwestern University
Philip Greenland, MD
Northwestern University
Peter Kahrilas, MD
Northwestern University
Philip Gorelick, MD
Northwestern University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”